Czechia Country Drug Report 2019

Drug-related infectious diseases

In Czechia, data on drug-related infections are available from national registers and studies involving different drug user groups. These data indicate that the rates of human immunodeficiency virus (HIV) infection/acquired immunodeficiency syndrome (AIDS), hepatitis B virus (HBV) infection and hepatitis C virus (HCV) infection among drug users have remained stable in recent years.

Prevalence of HIV and HCV antibodies among people who inject drugs in Czechia (%)
  Region HCV HIV
Data from 2016 (HIV) and from 2017 (HCV).
National 14.7 0.0 - 0.1
Sub-national : :

The number of newly diagnosed HIV-positive people among the general population is relatively low, with transmission among men who have sex with men identified as the dominant route overall. HIV seroprevalence rates among people who inject drugs (PWID) also remain low. The number of newly reported cases of acute HBV infection continues to decline. This is attributed to the routine vaccination programme for the general population introduced in 2001. In Czechia, more than half of newly reported cases of HCV infection in which the transmission route is known are in PWID. The latest available data from low-threshold facilities suggest that fewer than one in five clients of needle exchange programmes tested in these facilities were positive for HCV antibodies. A seroprevalence study among PWID is being conducted to provide a representative estimate.

Available data indicate that methamphetamine is the most prevalent injected drug in Czechia and that more than half of those who have ever injected drugs have shared their injecting equipment with peers.


Czechia main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.